Ketoconazole + Chloroxylenol + Benzyl Alcohol

Verify with FDA CVM →

13 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
13
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

Ketoconazole + Chloroxylenol + Benzyl Alcohol

Administration Routes

Auricular (Otic)Unknown

Species Affected

Dog 12
Cat 1

Most Affected Breeds

Spaniel - Cocker American 3
Retriever - Labrador 3
Poodle - Standard 1
Pug 1
Domestic Shorthair 1
Rottweiler 1
Brittany 1
Terrier - Yorkshire 1
Pointer (unspecified) 1

Most Reported Reactions

Not eating 3
Tenesmus 2
Diarrhoea 2
Lethargy (see also Central nervous system depression in 'Neurological') 2
Depression 2
Other abnormal test result NOS 2
Head tilt - ear disorder 2
Lack of efficacy - NOS 2
Hair modification NOS 1
Flaking skin 1
Swollen vulva 1
Decreased body temperature 1

Outcome Breakdown

Recovered/Normal
5 (38.5%)
Outcome Unknown
4 (30.8%)
Recovered with Sequela
2 (15.4%)
Ongoing
2 (15.4%)

Data Summary

Metric Value
Total adverse event reports 13
Reports involving death 0
Case-fatality rate (reported events) 0.0%
Distinct species in reports 2
Distinct breeds in reports 9
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Ketoconazole + Chloroxylenol + Benzyl Alcohol Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 13 adverse event reports referencing Ketoconazole + Chloroxylenol + Benzyl Alcohol, including 0 reports in which the animal died — a 0.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Ketoconazole + Chloroxylenol + Benzyl Alcohol. Reported administration routes include Auricular (Otic), Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Ketoconazole + Chloroxylenol + Benzyl Alcohol reports are Dog (12 reports), Cat (1 reports), with Dog accounting for the largest share. Within those species, Spaniel - Cocker American (3), Retriever - Labrador (3), Poodle - Standard (1) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Ketoconazole + Chloroxylenol + Benzyl Alcohol are Not eating (3), Tenesmus (2), Diarrhoea (2), Lethargy (see also Central nervous system depression in 'Neurological') (2). Of the 13 reports with a coded outcome, Recovered/Normal is the leading category at 38.5%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ketoconazole + Chloroxylenol + Benzyl Alcohol.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial